Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-043286
Filing Date
2018-11-16
Accepted
2018-11-16 16:54:02
Documents
1
Period of Report
2018-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3761
  Complete submission text file 0001140361-18-043286.txt   5255
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD SUITE 455 ROCKVILLE MD 20850
Business Address
Swirsky Douglas J (Reporting) CIK: 0001375884 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 181190410